DD155176A5 - Verfahren zur herstellung von derivaten cyclischer peptidkerne - Google Patents

Verfahren zur herstellung von derivaten cyclischer peptidkerne Download PDF

Info

Publication number
DD155176A5
DD155176A5 DD80226030A DD22603080A DD155176A5 DD 155176 A5 DD155176 A5 DD 155176A5 DD 80226030 A DD80226030 A DD 80226030A DD 22603080 A DD22603080 A DD 22603080A DD 155176 A5 DD155176 A5 DD 155176A5
Authority
DD
German Democratic Republic
Prior art keywords
dodecanoyl
column
amino
factor
alkyl
Prior art date
Application number
DD80226030A
Other languages
German (de)
English (en)
Inventor
Manuel Debono
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/182,248 external-priority patent/US4293491A/en
Priority claimed from US06/181,030 external-priority patent/US4293483A/en
Priority claimed from US06/181,435 external-priority patent/US4293488A/en
Priority claimed from US06/181,436 external-priority patent/US4293485A/en
Priority claimed from US06/181,040 external-priority patent/US4293487A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD155176A5 publication Critical patent/DD155176A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62—Streptosporangium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DD80226030A 1979-12-13 1980-12-12 Verfahren zur herstellung von derivaten cyclischer peptidkerne DD155176A5 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US10313179A 1979-12-13 1979-12-13
US10314979A 1979-12-13 1979-12-13
US10314779A 1979-12-13 1979-12-13
US10301579A 1979-12-13 1979-12-13
US10314879A 1979-12-13 1979-12-13
US06/182,248 US4293491A (en) 1979-12-13 1980-08-25 Derivatives of A-30912H nucleus
US06/181,030 US4293483A (en) 1979-12-13 1980-08-25 Derivatives of A-30912A nucleus
US06/181,435 US4293488A (en) 1979-12-13 1980-08-25 Derivatives of A-30912B nucleus
US06/181,436 US4293485A (en) 1979-12-13 1980-08-25 Derivatives of S31794/F-1 nucleus
US06/181,040 US4293487A (en) 1979-12-13 1980-08-25 Derivatives of A-30912D nucleus

Publications (1)

Publication Number Publication Date
DD155176A5 true DD155176A5 (de) 1982-05-19

Family

ID=27580997

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80226030A DD155176A5 (de) 1979-12-13 1980-12-12 Verfahren zur herstellung von derivaten cyclischer peptidkerne

Country Status (10)

Country Link
EP (1) EP0032009A1 (pt)
CA (1) CA1183127A (pt)
DD (1) DD155176A5 (pt)
DK (1) DK528080A (pt)
GB (1) GB2065136A (pt)
GR (1) GR72298B (pt)
IL (1) IL61648A0 (pt)
IT (1) IT1141133B (pt)
PT (1) PT72155A (pt)
YU (1) YU310780A (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1138149B (it) * 1980-08-15 1986-09-17 Sandoz Ag Metaboliti,loro preparazione e loro impiego in terapeutica
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5202309A (en) * 1989-06-30 1993-04-13 Merck & Co., Inc. Antibiotic cyclopeptide fermentation product
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
NZ234225A (en) * 1989-06-30 1993-09-27 Merck & Co Inc Antibiotic from zalerion arboricola and its use as an antifungal agent and antipneumocystis agent
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
CN1345333A (zh) 1999-03-03 2002-04-17 伊莱利利公司 棘白菌素/糖类复合物
EP1156782B1 (en) 1999-03-03 2005-05-04 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
CN102464703B (zh) * 2010-11-05 2014-07-09 上海医药工业研究院 一种获得高纯度棘白菌素d的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803584A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Aminoalkylaether der peptide tetrahydro-sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung

Also Published As

Publication number Publication date
GR72298B (pt) 1983-10-18
IT8026633A0 (it) 1980-12-12
CA1183127A (en) 1985-02-26
EP0032009A1 (en) 1981-07-15
GB2065136A (en) 1981-06-24
IL61648A0 (en) 1981-01-30
IT1141133B (it) 1986-10-01
DK528080A (da) 1981-06-14
PT72155A (en) 1981-01-01
YU310780A (en) 1983-02-28

Similar Documents

Publication Publication Date Title
DD155176A5 (de) Verfahren zur herstellung von derivaten cyclischer peptidkerne
DE68905119T2 (de) Methode zur kontrolle von pneumocystis carinii.
DE60103504T2 (de) Nasal verabreichbare cyclische antimykotische peptidzusammensetzungen
US4320052A (en) Derivatives of A-30912A nucleus
DD155178A5 (de) Verfahren zur herstellung von derivaten cyclischer peptidkerne
DE3109335C2 (de) Ebelacton A und B, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DD155250A5 (de) Verfahren zur herstellung cyclischer peptidkerne
US4293485A (en) Derivatives of S31794/F-1 nucleus
EP0646649B1 (en) Method of producing iturin A and antifungal agent for profund mycosis
US4293491A (en) Derivatives of A-30912H nucleus
US4293488A (en) Derivatives of A-30912B nucleus
US4293483A (en) Derivatives of A-30912A nucleus
EP0916680B1 (de) Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung desselben
EP1175435B1 (de) Cephaibole, antiparasitika aus acremonium tubakii, verfahren zu ihrer herstellung und verwendung derselben
DE60110908T2 (de) Antibiotische tripropeptine und verfahren ihrer herstellung
DD155177A5 (de) Verfahren zur herstellung von derivaten cyclischer peptidkerne
US4293487A (en) Derivatives of A-30912D nucleus
DE69917668T2 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
DE69837111T2 (de) Antibiotikum tkr2999, verfahren zur herstellung desselben sowie mikrobe
DE69913369T2 (de) Mikrobielle transformationsprodukte
DE69733016T2 (de) Physiologisch aktive tkr1785's substanzen, verfahren zu ihrer herstellung und mikrobe
EP0848064B1 (de) Neues Antibiotikum, Feglymycin, Verfahren zu seiner Herstellung und Verwendung
DE3889213T2 (de) Antibiotika NK 86-0279, deren Verfahren zur Herstellung und deren Benutzung.
EP0304400B1 (de) Phenanthridinderivate, Verfahren zu ihrer Herstellung und Mittel zur Ausführung des Verfahrens
DE4305249A1 (de) Galaktosylbrefeldin A, ein neuer Metabolit mit pharmakologischer Wirkung, ein Verfahren zu seiner Herstellung und seine Verwendung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee